Jammu, June 6 -- In a remarkable academic milestone for Indian dermatology, Dr. Mir Shahnawaz, a leading dermatologist and Founder & Director of DERMIS Skin & Hair Clinic, Bemina, has earned international acclaim with the publication of his groundbreaking research in the CUREUS Journal, a globally recognized, PubMed-indexed platform under Springer.

Titled "Clinical Assessment of Abrocitinib, Tofacitinib, and Cyclosporine in Adult Patients With Moderate to Severe Atopic Dermatitis: A Retrospective Analysis," the study represents the first comparative real-world clinical research from India to evaluate these three systemic therapies, including Abrocitinib, a novel selective JAK-1 inhibitor.Click Here To Follow Our WhatsApp Channel

Dr. Sha...